TG Therapeutics Inc. (TGTX) NASDAQ

$16.62 (0.30) (-1.77%)

Market Cap: $2.61B

As of 05/10/24 04:00 PM EDT. Market closed.

(TGTX)

TG Therapeutics Inc. (TGTX)
NASDAQ

$16.62
(0.30) (-1.77%)

Market Cap: $2.61B

As of 05/10/24 04:00 PM EDT. Market closed.

Add to Portfolio

tg therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for b-cell malignancies and autoimmune diseases. currently, the company is developing two therapies targeting hematological malignancies. tg-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a specific and unique epitope on the cd20 antigen ... read more

COMPANY PROFILE
Sector
Industry
CEO
Michael Weiss
Full Time Employees
276
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
URL
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
Sector
Industry
CEO
Michael Weiss
Full Time Employees
276
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
PRICE CHART FOR TG THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$17.05
Previous Close
$16.92
Days Range
$16.84 - $17.34
52 week range
$6.46 - $33.58
Volume
2,226,828
Avg. Volume (30 days)
4,304,947
Market Cap
$2.61B
Dividend Yield
-
P/E
62.88
Shares Outstanding
154,542,945
Open
$17.05
Previous Close
$16.92
Days Range
$16.84 - $17.34
52 week range
$6.46 - $33.58
Volume
2,226,828
Avg. Volume (30 days)
4,304,947
Market Cap
$2.61B
Dividend Yield
-
P/E
62.88
Shares Outstanding
154,542,945
FINANCIAL STATEMENTS FOR TG THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TG THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Lonial SagarDirectorMar 13, 2024 Sale$15.945,00079,675108,878Mar 15, 2024, 04:37 PM
Charney Laurence NDirectorMar 12, 2024 Sale$15.9722,000351,340215,229Mar 13, 2024, 04:52 PM
Charney Laurence NDirectorJan 05, 2024 Sale$19.0317,500333,025237,229Jan 08, 2024, 06:33 PM
Power Sean ACFOJan 03, 2024 Sale$16.9147,867809,431606,969Jan 05, 2024, 05:00 PM
WEISS MICHAEL SCEO and PresidentAug 11, 2023 Buy$10.13100,0001,013,00012,073,021Aug 14, 2023, 09:54 AM
Lonial SagarDirectorJun 23, 2023 Sale$23.3734,854814,53893,878Jun 26, 2023, 05:00 PM
Power Sean AChief Financial OfficerJun 02, 2023 Sale$26.7073,6471,966,375654,836Jun 05, 2023, 06:26 PM
Echelard YannDirectorJan 06, 2023 Buy$10.649,00095,760201,848Jan 06, 2023, 05:01 PM
Charney Laurence NDirectorJan 04, 2023 Sale$11.1030,000333,000234,729Jan 06, 2023, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 04, 2022 Sale$19.2075,3121,445,990578,136Jan 07, 2022, 06:11 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2022 Sale$18.319,653176,746568,483Jan 07, 2022, 06:11 PM
WEISS MICHAEL SCEO and PresidentJan 05, 2022 Sale$18.3130,671561,58610,988,021Jan 07, 2022, 06:00 PM
WEISS MICHAEL SCEO and PresidentJan 04, 2022 Sale$19.2037,549720,94113,455,697Jan 07, 2022, 06:00 PM
Echelard YannDirectorDec 10, 2020 Sale$40.0530,0001,201,500129,116Dec 11, 2020, 05:01 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 09, 2020 Sale$25.81158,5894,092,73812,629,868Sep 11, 2020, 04:31 PM
KENNEDY WILLIAM JAMESDirectorJun 17, 2020 Sale$18.277,745141,50194,633Jun 24, 2020, 07:48 PM
Power Sean ACFO, Secretary and TreasurerJul 01, 2019 Sale$8.4717,654149,529383,338Jul 03, 2019, 04:00 PM
WEISS MICHAEL SCEO and PresidentJun 26, 2019 Buy$7.0350,000351,75012,878,185Jun 27, 2019, 07:33 AM
Power Sean ACFO, Secretary and TreasurerJan 02, 2019 Sale$4.1337,275153,946400,992Jan 03, 2019, 07:21 PM
Power Sean ACFO, Secretary and TreasurerJul 03, 2018 Sale$13.1935,000461,650438,267Jul 05, 2018, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJul 02, 2018 Sale$13.2612,191161,653473,267Jul 05, 2018, 05:00 PM
KENNEDY WILLIAM JAMESDirectorJun 14, 2018 Sale$13.4525,071337,20560,330Jun 18, 2018, 04:30 PM
Power Sean ACFO, Secretary and TreasurerJan 02, 2018 Sale$8.5032,006272,051485,458Jan 03, 2018, 05:25 PM
Power Sean ACFO, Secretary and TreasurerJun 19, 2017 Sale$11.0430,000331,200447,464Jun 19, 2017, 06:05 PM
Power Sean ACFO, Secretary and TreasurerJun 16, 2017 Sale$11.1429,976333,933477,464Jun 19, 2017, 06:05 PM
KENNEDY WILLIAM JAMESDirectorApr 11, 2017 Sale$10.278,54887,78870,401Apr 12, 2017, 05:44 PM
Charney Laurence NDirectorApr 04, 2017 Sale$11.177,00078,19088,949Apr 04, 2017, 05:57 PM
Power Sean ACFO, Secretary and TreasurerJan 04, 2017 Sale$4.558,81640,113507,440Jan 04, 2017, 05:28 PM
Power Sean ACFO, Secretary and TreasurerJul 05, 2016 Sale$5.9950,426302,052416,256Jul 08, 2016, 08:06 PM
Power Sean ACFO, Secretary and TreasurerApr 18, 2016 Sale$10.1210,000101,200466,682Apr 20, 2016, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2016 Sale$11.2122,790255,476476,682Jan 07, 2016, 06:00 PM
KENNEDY WILLIAM JAMESDirectorJul 08, 2015 Sale$17.0817,000290,36066,490Jul 09, 2015, 09:41 PM
Power Sean ACFO, Secretary and TreasurerJul 01, 2015 Sale$16.4650,054823,889449,472Jul 02, 2015, 05:00 PM
LFB Biotechnologies S.A.S.U.10% OwnerFeb 17, 2015 Buy$6.53114,855750,0035,114,855May 11, 2015, 04:30 PM
LFB Biotechnologies S.A.S.U.10% OwnerMay 07, 2015 Option Exercise$0.002,500,0002,5007,614,855May 11, 2015, 04:30 PM
Power Sean ACFO, Secretary and TreasurerApr 02, 2015 Sale$15.5111,000170,610499,526Apr 03, 2015, 05:00 PM
Power Sean ACFO, Secretary and TreasurerApr 01, 2015 Sale$15.5012,800198,400510,526Apr 03, 2015, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 07, 2015 Sale$16.4012,344202,442523,326Jan 07, 2015, 08:50 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2015 Sale$16.4054,057886,448535,670Jan 07, 2015, 08:50 PM
WEISS MICHAEL SSee RemarksDec 16, 2014 Sale$16.44210,6183,462,5608,120,773Dec 18, 2014, 09:44 PM
Power Sean ACFO, Secretary and TreasurerDec 16, 2014 Sale$16.4438,041625,394579,727Dec 18, 2014, 09:37 PM
Power Sean ACFO, Secretary and TreasurerNov 21, 2013 Option Exercise$5.3823,106124,310542,768Jan 02, 2014, 07:00 PM
WEISS MICHAEL SSee RemarksDec 11, 2013 Buy$3.4310,00034,3007,839,471Dec 12, 2013, 06:06 AM
Power Sean ACFO, Secretary and TreasurerMay 17, 2012 Option Exercise$6.2513,52684,538490,874Jan 02, 2013, 08:11 PM
Herskowitz NeilDirectorDec 06, 2012 Buy$2.001,0002,00051,265Dec 12, 2012, 04:30 PM
Power Sean ACFO, Secretary and TreasurerSep 13, 2012 Buy$2.251,0002,250501,000Sep 17, 2012, 09:46 AM
Power Sean ACFO, Secretary and TreasurerSep 14, 2012 Buy$2.283,4007,752504,400Sep 17, 2012, 09:46 AM
WEISS MICHAEL SSee RemarksSep 11, 2012 Buy$2.25100,000225,0007,342,728Sep 11, 2012, 04:01 PM
WEISS MICHAEL SSee RemarksSep 10, 2012 Buy$2.2550,000112,5007,242,728Sep 11, 2012, 04:01 PM
WEISS MICHAEL SSee RemarksMay 16, 2012 Buy$6.251,5009,3755,192,728May 17, 2012, 05:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Lonial SagarDirector03/13/202479,675
Charney Laurence NDirector03/12/2024351,340
Charney Laurence NDirector01/05/2024333,025
Power Sean ACFO01/03/2024809,431
WEISS MICHAEL SCEO and President08/11/20231,013,000
Lonial SagarDirector06/23/2023814,538
Power Sean AChief Financial Officer06/02/20231,966,375
Echelard YannDirector01/06/202395,760
Charney Laurence NDirector01/04/2023333,000
Power Sean ACFO, Secretary and Treasurer01/04/20221,445,990
Power Sean ACFO, Secretary and Treasurer01/05/2022176,746
WEISS MICHAEL SCEO and President01/05/2022561,586
WEISS MICHAEL SCEO and President01/04/2022720,941
Echelard YannDirector12/10/20201,201,500
RA CAPITAL MANAGEMENT, L.P.10% Owner09/09/20204,092,738
KENNEDY WILLIAM JAMESDirector06/17/2020141,501
Power Sean ACFO, Secretary and Treasurer07/01/2019149,529
WEISS MICHAEL SCEO and President06/26/2019351,750
Power Sean ACFO, Secretary and Treasurer01/02/2019153,946
Power Sean ACFO, Secretary and Treasurer07/03/2018461,650
Power Sean ACFO, Secretary and Treasurer07/02/2018161,653
KENNEDY WILLIAM JAMESDirector06/14/2018337,205
Power Sean ACFO, Secretary and Treasurer01/02/2018272,051
Power Sean ACFO, Secretary and Treasurer06/19/2017331,200
Power Sean ACFO, Secretary and Treasurer06/16/2017333,933
KENNEDY WILLIAM JAMESDirector04/11/201787,788
Charney Laurence NDirector04/04/201778,190
Power Sean ACFO, Secretary and Treasurer01/04/201740,113
Power Sean ACFO, Secretary and Treasurer07/05/2016302,052
Power Sean ACFO, Secretary and Treasurer04/18/2016101,200
Power Sean ACFO, Secretary and Treasurer01/05/2016255,476
KENNEDY WILLIAM JAMESDirector07/08/2015290,360
Power Sean ACFO, Secretary and Treasurer07/01/2015823,889
LFB Biotechnologies S.A.S.U.10% Owner02/17/2015750,003
LFB Biotechnologies S.A.S.U.10% Owner05/07/20152,500
Power Sean ACFO, Secretary and Treasurer04/02/2015170,610
Power Sean ACFO, Secretary and Treasurer04/01/2015198,400
Power Sean ACFO, Secretary and Treasurer01/07/2015202,442
Power Sean ACFO, Secretary and Treasurer01/05/2015886,448
WEISS MICHAEL SSee Remarks12/16/20143,462,560
Power Sean ACFO, Secretary and Treasurer12/16/2014625,394
Power Sean ACFO, Secretary and Treasurer11/21/2013124,310
WEISS MICHAEL SSee Remarks12/11/201334,300
Power Sean ACFO, Secretary and Treasurer05/17/201284,538
Herskowitz NeilDirector12/06/20122,000
Power Sean ACFO, Secretary and Treasurer09/13/20122,250
Power Sean ACFO, Secretary and Treasurer09/14/20127,752
WEISS MICHAEL SSee Remarks09/11/2012225,000
WEISS MICHAEL SSee Remarks09/10/2012112,500
WEISS MICHAEL SSee Remarks05/16/20129,375
Load More Insider Transactions
FUNDS WITH A POSITION IN TG THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.10,843,5020.00384%0.7%Other
GEODE CAPITAL MANAGEMENT, LLC3,096,6460.00553%5.55%Other
RENAISSANCE TECHNOLOGIES LLC839,2000.02%-39.03%Other
BALYASNY ASSET MANAGEMENT L.P.425,0990.01%190.48%Event Driven
D. E. SHAW & CO., INC.262,7780.00392%94.37%Other
DRIEHAUS CAPITAL MANAGEMENT LLC185,4410.04%NewGrowth
GOTHAM ASSET MANAGEMENT, LLC96,2500.03%34.76%Other
UBS OCONNOR LLC50,000 (Call)0.00396%NewValue
TUDOR INVESTMENT CORP ET AL41,8350.00575%-55.8%Event Driven, Other
AQR CAPITAL MANAGEMENT LLC17,8870.00058%-70.12%Other
D. E. SHAW & CO., INC.11,200 (Call)0.00017%No changeOther
CHANGE IN SHARES OUTSTANDING FOR TG THERAPEUTICS INC
STOCK BUYBACKS FOR TG THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
-6.38%
1Q
03/31/2024
09/30/2023
-6.20%
2Q
03/31/2024
06/30/2023
3.33%
3Q
03/31/2024
03/31/2023
4.20%
4Q
03/31/2024
12/31/2022
6.62%
5Q
03/31/2024
09/30/2022
8.04%
6Q
03/31/2024
06/30/2022
8.48%
7Q
03/31/2024
03/31/2022
8.79%
8Q
03/31/2024
12/31/2021
10.30%
9Q
03/31/2024
09/30/2021
10.47%
10Q
03/31/2024
06/30/2021
10.70%
11Q
03/31/2024
03/31/2021
10.85%
12Q
03/31/2024
12/31/2020
17.73%
13Q
03/31/2024
09/30/2020
22.68%
14Q
03/31/2024
06/30/2020
30.13%
15Q
03/31/2024
03/31/2020
38.64%
16Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
-6.38%
1Q
09/30/2023
-6.20%
2Q
06/30/2023
3.33%
3Q
03/31/2023
4.20%
4Q
12/31/2022
6.62%
5Q
09/30/2022
8.04%
6Q
06/30/2022
8.48%
7Q
03/31/2022
8.79%
8Q
12/31/2021
10.30%
9Q
09/30/2021
10.47%
10Q
06/30/2021
10.70%
11Q
03/31/2021
10.85%
12Q
12/31/2020
17.73%
13Q
09/30/2020
22.68%
14Q
06/30/2020
30.13%
15Q
03/31/2020
38.64%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TG THERAPEUTICS INC
LOADING...